Hormonal contraception

Xem 1-12 trên 12 kết quả Hormonal contraception
  • COMBINED ORAL CONTRACEPTIVES Mechanism of action The combined oral contraceptive (COC) pills currently available in the UK are shown in Table 2. They combine an estrogen (ethinylestradiol (EE) in all cases but one) with one of seven progestogens. Aside from secondary contraceptive effects on the cervical mucus and to impede implantation, COCs primarily prevent ovulation. This makes the method highly effective in ‘perfect’ use (Table 1), but it removes the normal menstrual cyle and replaces it with a cycle that is user-produced and based only on the end-organ, i.e. the endometrium.

    pdf57p lananhanh123 27-08-2011 22 5   Download

  • The text of this manual, an update of the second edition of our Concise Guide to Women’s Mental Health, reflects the latest data on women’s mental health. Although every section has been revised, particularly extensive revisions have been made in the sections describing the use of psychiatric medications in pregnant and breast-feeding women, abortion and contraception, and the use of hormones in menopausal women. The book continues to reflect our expanding clinical experiences in the Women’s Life Center.

    pdf224p crius75 09-01-2013 22 3   Download

  • Contraceptive methods can be divided into two subgroups as hormonal and non-hormonal. Hormonal contraceptives include combined-oral contraceptives, progestin only pills, hormonal implants, progestin releasing intrauterine systems, depomedroxyprogesterone acetate injections, and vaginal rings. Non-hormonal contraceptive methods include male and female condoms, copper intrauterine device, tubal ligation and vasectomy of the companion. Combined oral contraceptives are a widely used and well accepted form of contraception.

    pdf360p ti_du_hoang 15-08-2012 30 8   Download

  • For the purposes of excluding pregnancy, the CEU would advise that hormonal, intrauterine and barrier methods can be considered reliable providing they have been used consistently and correctly on every incidence of intercourse. This should be assessed on an individual basis. Quick starting may also mean starting a method immediately after the administration of emergency contraception (EC). In this situation there is a possibility of EC failure and pregnancy, therefore such practice would always be outside the licence of hormonal contraceptives.

    pdf16p le_minh_nha 25-12-2012 36 4   Download

  • When starting hormonal contraception after POEC (Levonelle 1500® or Levonelle One Step®) additional contraception should be advised until contraceptive efficacy is established (see Summary on page iv). There are no data on quick starting hormonal contraception after use of the emergency contraceptive, ulipristal acetate (UPA) (ellaOne®). As UPA is a progesterone receptor modulator that blocks the action of progesterone, it may affect the contraceptive efficacy of hormonal methods.35,36 However, no interaction studies have been carried out to date.

    pdf0p le_minh_nha 25-12-2012 17 4   Download

  • A Cochrane review has found limited evidence that immediate (‘quick’) start of hormonal contraception reduces unintended pregnancies or improves continuation rates.15 None of the studies included in the review were powered to detect contraceptive efficacy. Whilst there is currently a paucity of evidence demonstrating effectiveness, there are data to suggest women find quick starting acceptable. It is possible that effectiveness may vary depending on method type.

    pdf5p le_minh_nha 25-12-2012 15 3   Download

  • The half-life of UPA is 32.4 hours, which means that most of the drug is eliminated by 1 week and the interaction with hormonal contraception is likely to be clinically insignificant by this time. If a hormonal method is quick started the CEU advises use of additional contraceptive precautions for 1 week after taking UPA plus the time required for contraceptive efficacy to be established (see Summary on page iv).

    pdf13p le_minh_nha 25-12-2012 16 3   Download

  • On the federal level, three agencies regulate ART. The Centers for Disease Control and Prevention (CDC) collects and publishes data on ART procedures. The Food and Drug Administration (FDA) controls approval and use of drugs, biological products, and medical devices and has jurisdiction over screening and testing of reproductive tissues, such as donor eggs and sperm. The Centers for Medicare and Medicaid Services (CMS) is responsible for implementation of the Clinical Laboratory Improvement Act to ensure the quality of laboratory testing....

    pdf19p le_minh_nha 25-12-2012 22 3   Download

  • Inadvertent fetal exposure to contraceptive hormones is common, with a USA study estimating that approximately 70 000 fetuses are exposed to oral contraceptives annually.23 Most of the data on fetal outcomes relate to COC. The CEU found no studies that specifically assessed exposure through quick starting contraception. Studies are often limited by their observational nature, potential confounding factors and small sample size. Reassuringly there have been no consistent findings of specific fetal abnormalities.

    pdf22p le_minh_nha 25-12-2012 21 6   Download

  • Estrogen acts as a proconvulsant in several animal models of epilepsy, including amygdalal kindling and pentylenetetrazol administration in ovariectomized rats (Hom and Buterbaugh, 1986). Estrogen induces the formation of new excitatory synapses in the CA1 region of the hippocampus; and further, this estrogenic induction involves activation of Nmethyl- Daspartate (NMDA) receptors (McEwen, 2002). Increasing the complexity of hippocampal synaptic density is likely a mechanism for the proconvulsant activity of estrogen.

    pdf246p ti_du_hoang 15-08-2012 35 3   Download

  • The appropriate time to start contraception depends on the contraceptive method and may also depend on medical and social factors. Traditionally, initiation of hormonal and intrauterine methods of contraception has been delayed until the onset of the next menstrual period in order to avoid inadvertent use during pregnancy. Starting early in the cycle also avoids the need for additional contraception. The manufacturers’ Summaries of Product Characteristics (SPCs) vary in their advice on contraceptive start dates and the need for additional contraception.

    pdf28p le_minh_nha 25-12-2012 23 3   Download

  • Approach to the Patient: Hepatocellular Carcinoma History and Physical The history is important in evaluating putative predisposing factors, including a history of hepatitis or jaundice, blood transfusion, or use of intravenous drugs. A family history of HCC or hepatitis should be sought, and a detailed social history taken to include job descriptions for industrial exposure to possible carcinogenic drugs as well as contraceptive hormones.

    pdf5p konheokonmummim 03-12-2010 32 2   Download

Đồng bộ tài khoản